Noom Med vs Calibrate 2026: GLP-1 Weight Loss Programs Compared
Noom Med and Calibrate both pair GLP-1 medication with premium coaching for weight loss. We compare pricing, coaching philosophies, clinical evidence, medication access, and contracts side-by-side, and show where a medication-focused provider like Trimi fits in.
Written by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. Our team updates competitor reviews when pricing, medication access, or program structures change so patients can compare options with current data.
Quick links: Semaglutide treatment, tirzepatide treatment, and cheapest GLP-1 injections guide.
More on GLP-1 Provider Comparisons
Noom vs Calibrate for Weight Loss: What You Need to Know
If you are comparing noom vs calibrate for GLP-1 weight loss, you are choosing between two coaching-heavy telehealth programs that pair prescription medication with structured behavioral support. Noom Med combines semaglutide prescriptions with its behavioral psychology app, while Calibrate delivers a metabolic health coaching program alongside GLP-1 medication. Both charge premium prices because they bundle coaching into the cost of treatment, and both target patients who want more than just a prescription.
Noom Med vs Calibrate, defined: Noom Med is the prescription arm of Noom, the popular weight loss app known for its cognitive behavioral therapy approach to food and habits, now expanded to include GLP-1 medications. Calibrate is a standalone telehealth company built around its Metabolic Reset program, which combines GLP-1 medication with intensive coaching across food, exercise, sleep, and emotional health. Both are legitimate telehealth providers with licensed medical teams, but they differ meaningfully in coaching philosophy, pricing structure, contract terms, and overall cost.
The central question for most patients is whether the coaching bundled into these programs is worth it to them compared with a medication-focused provider. Clinical trial data shows that GLP-1 medication is the primary driver of weight loss. The STEP 1 trial demonstrated 14.9% body weight loss with semaglutide at 68 weeks, with both the treatment and placebo groups receiving lifestyle counseling (Wilding et al., NEJM, 2021). The coaching both groups received contributed roughly the same amount, while the medication accounted for the difference in outcomes. Patients who want medication-focused GLP-1 care without a coaching program may prefer a provider like Trimi, which offers compounded semaglutide at $99 per month and tirzepatide at $125 per month on the annual plan, a 12-month commitment, with clinical oversight included. Compounded medications are not FDA-approved, and Calibrate's FAQ states that it does not prescribe compounded GLP-1 medications.
Noom Med vs Calibrate vs Trimi: Side-by-Side Comparison
| Feature | Noom Med | Calibrate | Trimi |
|---|---|---|---|
| Semaglutide monthly cost | $149--$209/mo | Monthly membership plus separately billed brand-name medication | $99/mo |
| Tirzepatide monthly cost | Limited availability | Monthly membership plus separately billed brand-name medication | $125/mo |
| Additional app/coaching fee | $32--$70/mo possible | Included in program fee | None |
| Coaching model | App-based CBT + psychology | 1-on-1 metabolic health coaching | Clinical guidance |
| Medication included in price | Yes (med subscription) | No (billed separately) | Yes |
| Flat dose-independent pricing | No | No | Yes |
| Lab work required | No | Lab tests not included in membership | No (recommended when indicated) |
| Provider visits included | Yes | Yes | Yes |
| Contract commitment | Varies by plan | Initial 3 months, then month to month | $99/$125 annual plan is a 12-month commitment; month-to-month available at $175/$235 |
| Cancellation penalties | Possible | Initial 3-month commitment | None on month-to-month plans; the annual plan is a 12-month commitment backed by a 6-month money-back policy |
| Estimated 12-month total | $2,172--$3,348 | Membership plus medication; varies with insurance | $1,188 |
| Best for | Patients who value behavioral psychology app alongside medication | Patients wanting intensive metabolic coaching + insurance med access | Patients wanting flat-priced compounded GLP-1 care (not FDA-approved) |
All pricing is approximate and based on publicly available information as of April 2026. Noom Med's effective monthly total includes the potential additional Noom app subscription fee. Calibrate's total varies significantly based on insurance coverage for medication. Verify current pricing directly with each provider before enrolling.
Pricing Breakdown: What You Actually Pay
Cost is the most consequential difference between Noom Med and Calibrate for most patients, and both programs have pricing structures that are more complex than a single monthly number. Understanding the full financial commitment before enrolling is essential, because neither program is inexpensive and the total annual costs can differ by thousands of dollars.
Noom Med Pricing
Noom Med charges $149 to $209 per month for its semaglutide medication subscription, covering the prescription, clinical oversight, and medication delivery. However, the Noom coaching app is a separate product with its own subscription fee of $32 to $70 per month depending on the plan and billing cycle. Some patients report bundled pricing that reduces the combined cost, but the total effective monthly expense for Noom Med with full coaching access typically ranges from $181 to $279 per month for semaglutide. Over 12 months, that totals $2,172 to $3,348 for medication and coaching combined. Tirzepatide availability through Noom Med is limited, and pricing for it may differ. For a detailed look at potential issues, see our guide on Noom Med side effects.
Calibrate Pricing
As of October 2026, Calibrate's pricing page lists its Metabolic Reset membership at $199 per month with an initial 3-month commitment ($597 in total, paid in monthly installments), after which the membership renews monthly. This program fee covers the coaching, structured curriculum, and provider consultations. Calibrate states that lab tests and prescription medications are not included in its membership cost, and its FAQ states that it does not prescribe compounded GLP-1 medications. Calibrate has primarily worked with brand-name GLP-1 medications through insurance pathways. If insurance covers the medication, patients pay their copay on top of the program fee. If insurance does not cover the medication, check with Calibrate for out-of-pocket medication costs, since Calibrate does not list a cash price for GLP-1 medication on its pricing page. Calibrate says its program fee is not covered by insurance but is HSA/FSA eligible. For details on potential issues with Calibrate's program, see our Calibrate side effects guide.
Trimi Pricing
Trimi charges $99 per month for semaglutide and $125 per month for tirzepatide on the annual plan, a 12-month commitment. The price is flat and dose-independent, meaning you pay the same amount whether you are on a starting dose or a maintenance dose. There are no additional fees for app access, coaching, consultations, or shipping. The 12-month total for semaglutide at Trimi is $1,188 with no risk of price escalation. Compared to Noom Med's midpoint cost of approximately $2,760, Trimi saves patients approximately $1,572 annually. For a comprehensive comparison of affordable GLP-1 options, see our cheapest GLP-1 injections 2026 guide.
Annual Cost Perspective
GLP-1 therapy is typically sustained for 12 to 24 months or longer for optimal results. Small monthly differences compound into significant annual savings. A patient choosing Trimi over Noom Med saves roughly $1,000 to $2,100 per year. These savings can be redirected toward nutrition, exercise, or other health investments that support your weight loss goals.
Coaching Philosophies: Behavioral Psychology vs Metabolic Reset
The coaching component is what distinguishes both Noom Med and Calibrate from medication-focused providers. Both platforms charge a significant premium for coaching, but their approaches differ meaningfully in philosophy, structure, and delivery. Understanding these differences helps you decide whether either coaching model justifies its cost for your situation.
Noom Med Coaching
Rooted in cognitive behavioral therapy (CBT) principles
App-based daily lessons on food psychology and habit formation
Color-coded food classification system (green, yellow, red)
Daily calorie logging and meal tracking within the Noom app
Group coaching with other Noom users and optional 1-on-1 sessions
Focus on changing your psychological relationship with food
Self-directed pace through app curriculum modules
Calibrate Coaching
Structured metabolic reset curriculum
Dedicated 1-on-1 health coach assigned to each patient
Four-pillar framework: food, exercise, sleep, emotional health
Metabolic lab work to establish baselines and track progress
Sequenced modules patients progress through over the program
Focus on resetting the body's metabolic set point holistically
Provider-guided pace with defined program milestones
Noom Med's coaching is better suited for patients who want a technology-driven, self-paced behavioral psychology program they can engage with on their phone throughout the day. The CBT foundation is evidence-informed and particularly strong for patients who struggle with emotional eating, food guilt, or deeply ingrained eating patterns. Calibrate's coaching is more clinically structured and comprehensive, with a dedicated coach guiding patients through a defined curriculum that addresses not just food but exercise, sleep, and stress management as interconnected metabolic factors.
Calibrate's approach has genuine clinical merit for patients with complex metabolic profiles or multiple failed weight loss attempts who need the accountability and structure of a guided program. Noom Med's approach has merit for patients who prefer digital self-directed learning and want the behavioral psychology toolkit alongside their medication. The honest question for both programs is whether you will consistently engage with the coaching tools over 12 or more months, or whether your engagement will taper after the initial motivation fades.
The coaching premium question
Noom Med charges significantly more than medication-focused providers because of its coaching component. Research consistently shows that GLP-1 medication drives the majority of weight loss outcomes. Patients who are self-motivated, already knowledgeable about nutrition and exercise, or unlikely to engage daily with coaching tools for a full year may prefer a medication-focused provider like Trimi, which offers compounded semaglutide and tirzepatide that are not FDA-approved.
Clinical Evidence: What Actually Drives Weight Loss
Neither Noom Med nor Calibrate has published peer-reviewed clinical trials demonstrating that their specific coaching programs produce weight loss outcomes superior to GLP-1 medication with standard clinical oversight. The evidence base for GLP-1 weight loss comes from large-scale randomized controlled trials of the medications themselves, not from any individual platform's coaching methodology. This distinction matters because both programs charge a premium specifically for coaching, yet the evidence attributes the majority of weight loss to the medication.
Semaglutide: STEP 1 Trial Results
The STEP 1 trial enrolled 1,961 adults and demonstrated that semaglutide 2.4 mg produced an average of 14.9% body weight loss over 68 weeks, compared to 2.4% with placebo. Both groups received lifestyle counseling, meaning the medication, not the counseling, drove the 12.5 percentage point difference (Wilding et al., New England Journal of Medicine, 2021). The trial studied FDA-approved semaglutide; compounded preparations, such as Trimi's, are not FDA-approved and were not studied in it.
Tirzepatide: SURMOUNT-1 Trial Results
The SURMOUNT-1 trial enrolled 2,539 adults and demonstrated that tirzepatide produced up to 22.5% body weight loss at the highest dose over 72 weeks, compared to 3.1% with placebo. Both groups received lifestyle counseling. The dual GIP/GLP-1 mechanism of tirzepatide produced even greater weight loss than semaglutide alone (Jastreboff et al., New England Journal of Medicine, 2022). Trimi offers compounded tirzepatide, which is not FDA-approved and was not studied in SURMOUNT-1, at $125 per month on the annual plan; Calibrate may offer brand-name tirzepatide through insurance pathways; Noom Med's tirzepatide availability is limited.
Intensive Coaching vs Standard Counseling
A study by Wadden et al. compared semaglutide plus intensive behavioral therapy against semaglutide with standard counseling. Both groups achieved significant weight loss, and the intensive therapy group did not demonstrate a clinically meaningful advantage over the standard counseling group. This finding is directly relevant to the Noom Med and Calibrate pricing discussion: their intensive coaching programs may not produce materially better outcomes than basic clinical guidance alongside GLP-1 medication.
SELECT Cardiovascular Trial
The SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events with semaglutide in patients with obesity and established cardiovascular disease (Lincoff et al., New England Journal of Medicine, 2023). This cardiovascular benefit is attributable to the medication itself, independent of any coaching methodology, further reinforcing that the pharmacological intervention is the primary therapeutic driver.
The evidence is consistent: GLP-1 medications produce substantial, clinically meaningful weight loss and cardiovascular benefits. Coaching and behavioral support are beneficial for overall health and habit formation, but they are not the primary mechanism of weight loss in GLP-1 treatment. Patients should evaluate whether the coaching premiums charged by Noom Med and Calibrate align with their individual needs and budget, knowing that the medication accounts for the vast majority of expected clinical outcomes.
Medication Options and Access
All three providers prescribe semaglutide for weight loss. Semaglutide is a GLP-1 receptor agonist; see our guide to its side effect profile. Brand-name semaglutide is FDA-approved, while compounded semaglutide is not. The differences are in medication type availability, formulation (brand-name vs compounded), and how medication cost is structured.
Noom Med medications
Primarily semaglutide. Tirzepatide availability is limited and may vary. Compounded and brand-name options may be available depending on supply and market conditions.
Calibrate medications
Has historically focused on brand-name GLP-1 medications accessed through insurance; as of October 2026, Calibrate's FAQ states that it does not prescribe compounded GLP-1 medications. Prescription medications are not included in the membership cost, creating variable total cost depending on insurance coverage.
Trimi medications
Semaglutide ($99/mo) and tirzepatide ($125/mo) on the annual plan, a 12-month commitment. Compounded formulations, not FDA-approved, from a state-licensed 503A community sterile-compounding pharmacy, BelieveRx. Flat pricing at all doses with medication, consultation, and shipping included.
Calibrate's insurance-first approach works well for patients with strong GLP-1 coverage, potentially reducing medication costs to a copay. For the majority of patients paying out of pocket, however, Trimi's flat monthly pricing on compounded semaglutide and tirzepatide makes sustained long-term treatment financially predictable without insurance dependency; those preparations are made by state-licensed pharmacies against an individual prescription and are not FDA-approved as drugs. Noom Med sits in between, offering medication through its subscription at $149 to $209 per month for semaglutide, with the added variable of a possible separate Noom app fee.
Who Should Choose Noom Med
Noom Med is the right fit if you specifically value the Noom app's behavioral psychology approach and want to combine cognitive behavioral therapy techniques with GLP-1 medication. Patients who have used the Noom app before and found its color-coded food system and daily lessons helpful may appreciate the continuity of using the same platform with medication added. The app-based, self-paced format suits patients who prefer digital engagement over scheduled coaching calls.
Noom Med is not the right choice if cost efficiency is a priority. At $181 to $279 per month effective cost including the app subscription, Noom Med is substantially more expensive than medication-focused alternatives. Patients who are primarily interested in the medication and unlikely to engage with daily app lessons for months on end are paying for coaching they will not fully use. If you are currently on Noom Med and considering a switch, our guide to canceling Noom Med details the transition process step by step.
Who Should Choose Calibrate
Calibrate is the right fit if you want the most comprehensive, clinically structured weight loss program available and are willing to commit to an initial 3-month membership term. The dedicated 1-on-1 coaching, four-pillar metabolic framework, lab work, and sequenced curriculum are genuinely impressive for patients who will fully engage with every component. Insurance navigation may reduce medication costs for patients with GLP-1 coverage, potentially making Calibrate more competitive on total cost.
Calibrate is not the right choice if you want a program without an initial commitment or with medication included in the price. The membership carries an initial 3-month commitment, and lab tests and prescription medications are not included in the membership cost. If you are currently on Calibrate and exploring alternatives, our guide to canceling Calibrate covers the process and contract considerations.
Who Should Choose Trimi
Trimi is the right fit if you want compounded GLP-1 treatment, which is not FDA-approved, without a bundled coaching program you may not fully use. Flat pricing ($99/mo semaglutide, $125/mo tirzepatide on the annual plan, a 12-month commitment), no membership fee, no hidden fees, and responsive clinical support make Trimi a financially straightforward option. Access to both semaglutide and tirzepatide at dose-independent pricing means your cost never increases as your treatment progresses through the titration schedule.
Trimi is not the right choice if you specifically want intensive app-based coaching (Noom Med) or a structured metabolic reset program (Calibrate). Trimi's model focuses on clinical medication management and provider oversight rather than comprehensive behavioral programming. The trade-off is clear: patients who choose Trimi forgo the coaching platforms that Noom Med and Calibrate provide. For patients who are self-motivated, already knowledgeable about nutrition and exercise, or prefer to supplement their medication with independent lifestyle strategies, this trade-off strongly favors Trimi.
The Bottom Line
Medication drives the clinical outcome, not coaching
In the STEP 1 and SURMOUNT-1 trials, brand-name semaglutide and tirzepatide produced 14.9% and 20.9% body weight loss, with coaching contributing a marginal additional benefit at best (Wilding et al., NEJM, 2021; Jastreboff et al., NEJM, 2022). Those trials did not study compounded preparations, which are not FDA-approved. When you pay more at Noom Med, you are primarily paying for coaching; Calibrate's FAQ states that it does not prescribe compounded GLP-1 medications.
Noom Med costs more than Trimi; Calibrate's total depends on insurance
For semaglutide over 12 months: Noom Med totals $2,172 to $3,348, and Trimi totals $1,188. Choosing Trimi over Noom Med saves roughly $1,000 to $2,100 a year, which adds up over a treatment course that often continues for years. Calibrate's membership does not include lab tests or prescription medications, so check with Calibrate for out-of-pocket medication costs.
Both coaching programs are well-designed but serve different patients
Noom Med excels at app-based behavioral psychology for self-directed learners. Calibrate excels at structured, clinician-guided metabolic coaching for patients who want maximum accountability. Neither has published evidence showing its coaching produces better weight loss than medication with standard clinical oversight. Choose the coaching model that fits your learning style, or skip the coaching premium entirely if you are self-motivated.
Start with the medication, add coaching if you need it
Rather than starting with an expensive coaching-plus-medication program and downgrading later, consider starting with a cost-effective medication provider like Trimi. If you find you need additional behavioral support after beginning treatment, standalone coaching apps and nutritional counseling are available independently and often at lower cost than the premium bundled by Noom Med.
Frequently Asked Questions
Is Noom Med the same as regular Noom?
No. Regular Noom is a behavioral weight loss app built around cognitive behavioral therapy techniques without medication. Noom Med is a separate clinical arm that pairs GLP-1 medications such as semaglutide with Noom's app-based coaching. Noom Med requires a medical evaluation and prescription, and the medication subscription ($149 to $209 per month) is separate from the optional Noom app subscription ($32 to $70 per month). The two products share branding but differ substantially in scope and cost.
What is Calibrate's metabolic reset?
Calibrate's metabolic reset is a structured program that combines GLP-1 medication with coaching across four pillars: food, exercise, sleep, and emotional health. The concept is based on the science of metabolic set point theory, which holds that the body defends a particular weight range through hormonal and neurological mechanisms. Calibrate uses medication to address the hormonal component while coaching targets behavioral factors across all four pillars simultaneously. The membership includes structured curriculum modules, dedicated coaching, and provider oversight; as of October 2026, Calibrate states that lab tests and prescription medications are not included in its membership cost.
Which is more expensive, Noom Med or Calibrate?
It depends on your insurance coverage. As of October 2026, Calibrate bills its Metabolic Reset membership monthly with an initial 3-month commitment, and lab tests and prescription medications are not included in the membership cost, so total spending depends on insurance and medication source. Noom Med charges $149 to $209 per month for the medication subscription with a possible additional Noom app fee of $32 to $70 per month, totaling approximately $2,172 to $3,348 annually. Noom Med is significantly more expensive than medication-focused providers like Trimi, which charges $99 per month for semaglutide on the annual plan, a 12-month commitment ($1,188 annually).
Does Calibrate require a one-year contract?
No. As of October 2026, Calibrate's pricing page lists its Metabolic Reset membership at $199 per month with an initial 3-month commitment, for a total commitment of $597 paid in monthly installments, and its membership terms say the membership then renews automatically for one-month terms. Lab tests and prescription medications are not included in the membership cost. Noom Med's commitment terms vary by plan.
Do I need coaching to lose weight on GLP-1 medication?
Clinical evidence shows that GLP-1 medication is the primary driver of weight loss. The STEP 1 trial demonstrated 14.9 percent body weight loss with semaglutide compared to 2.4 percent with placebo, and both groups received lifestyle counseling (Wilding et al., NEJM, 2021). The coaching that both groups received contributed roughly the same amount. While coaching can support habit formation and long-term sustainability, the medication produces the vast majority of the clinical weight loss effect. Many patients achieve excellent results with medication and standard clinical oversight alone.
Can I switch from Noom Med or Calibrate to another provider?
Yes. Complete your new provider's health assessment and share your current treatment history including medication, dose, and any lab results; the new provider decides whether to continue your GLP-1 therapy and at what dose. Moving from a brand-name medication to a compounded preparation, which is not FDA-approved, is a clinical decision to make with that provider. The main considerations are timing the switch to avoid a medication supply gap and reviewing any contract terms or cancellation penalties with your current provider. Calibrate's membership has an initial 3-month commitment, so review your agreement carefully before switching.
Does Noom Med offer tirzepatide?
Noom Med has historically focused on semaglutide as its primary GLP-1 medication. Tirzepatide availability through Noom Med is more limited and may vary by region and supply. For patients specifically seeking tirzepatide, Calibrate may offer it through insurance pathways, and Trimi offers compounded tirzepatide, which is not FDA-approved, at $125 per month on the annual plan with flat pricing regardless of dose. If tirzepatide is your preferred medication, confirm availability directly with Noom Med before enrolling.
Sources & References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216.
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221-2232.
- Wadden TA, et al. Intensive behavioral therapy and semaglutide for obesity. N Engl J Med. 2024.
- Noom Health, Inc. Noom Med official program and pricing information. 2026.
- Calibrate Health, Inc. Official website and program information. 2026.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Individual results vary. Trimi is a competing provider; this comparison is presented fairly but readers should verify current pricing and program details directly with each provider. Pricing information reflects publicly available data as of April 2026 and is subject to change.